Sam A (Korea) Performance
| 009300 Stock | KRW 16,330 470.00 2.80% |
The entity has a beta of -0.28, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Sam A are expected to decrease at a much lower rate. During the bear market, Sam A is likely to outperform the market. At this point, Sam A Pharm has a negative expected return of -0.38%. Please make sure to validate Sam A's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Sam A Pharm performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Sam A Pharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -19.8 B |
Sam |
Sam A Relative Risk vs. Return Landscape
If you would invest 2,061,304 in Sam A Pharm Co on November 3, 2024 and sell it today you would lose (428,304) from holding Sam A Pharm Co or give up 20.78% of portfolio value over 90 days. Sam A Pharm Co is generating negative expected returns and assumes 1.8659% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Sam, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Sam A Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sam A's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sam A Pharm Co, and traders can use it to determine the average amount a Sam A's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2057
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 009300 |
Estimated Market Risk
| 1.87 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Sam A is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sam A by adding Sam A to a well-diversified portfolio.
Sam A Fundamentals Growth
Sam Stock prices reflect investors' perceptions of the future prospects and financial health of Sam A, and Sam A fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sam Stock performance.
| Return On Equity | 6.38 | |||
| Return On Asset | 0.0117 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 38.39 B | |||
| Shares Outstanding | 6.1 M | |||
| Price To Earning | 14.29 X | |||
| Price To Sales | 1.77 X | |||
| Revenue | 54.67 B | |||
| EBITDA | 7.17 B | |||
| Cash And Equivalents | 7.98 B | |||
| Total Debt | 1.51 B | |||
| Debt To Equity | 1.70 % | |||
| Cash Flow From Operations | 12.94 B | |||
| Total Asset | 189.17 B | |||
| Retained Earnings | 122.54 B | |||
| Current Asset | 74.43 B | |||
| Current Liabilities | 8.91 B | |||
About Sam A Performance
By analyzing Sam A's fundamental ratios, stakeholders can gain valuable insights into Sam A's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sam A has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sam A has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about Sam A Pharm performance evaluation
Checking the ongoing alerts about Sam A for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sam A Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sam A Pharm generated a negative expected return over the last 90 days | |
| About 66.0% of the company shares are owned by insiders or employees |
- Analyzing Sam A's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sam A's stock is overvalued or undervalued compared to its peers.
- Examining Sam A's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sam A's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sam A's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sam A's stock. These opinions can provide insight into Sam A's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sam Stock analysis
When running Sam A's price analysis, check to measure Sam A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam A is operating at the current time. Most of Sam A's value examination focuses on studying past and present price action to predict the probability of Sam A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam A's price. Additionally, you may evaluate how the addition of Sam A to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |